| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/14/2006 | US7012066 for coadministration with interferon and antiviral agent |
| 03/14/2006 | US7012062 Use of modified lysozyme C to prepare medicinal compositions for the treatment of some serious diseases |
| 03/14/2006 | US7011968 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 03/14/2006 | US7011964 Use of an enzyme for the manufacture of an agent for controlling bacterial infection |
| 03/14/2006 | US7011849 Second release phase formulation |
| 03/14/2006 | US7011845 For therapy and prophylaxis of infection or tumor |
| 03/14/2006 | US7011839 Combination of an antimicrobial, especially a quinolone antibiotic, and silver sulfadiazine |
| 03/14/2006 | US7011836 Neisseria having mutations in genes which causes the bacterium to lack endotoxic lipopolysaccharides, used for inoculation; genetic engineering; knockouts |
| 03/14/2006 | US7011820 Delivery of compounds for the treatment of Parkinsons through an inhalation route |
| 03/14/2006 | CA2376748C Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2103838C Novel 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 03/09/2006 | WO2006026619A2 Inhibition of viruses using rnase h inhibitors |
| 03/09/2006 | WO2006026352A1 Acylsulfonamide compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 03/09/2006 | WO2006025536A1 Anti-sars virus agent |
| 03/09/2006 | WO2006025475A1 Novel carbapenem compound |
| 03/09/2006 | WO2006024770A2 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 03/09/2006 | WO2006024741A2 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 03/09/2006 | WO2006024668A1 Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl] amino]benzonitrile |
| 03/09/2006 | WO2006024667A1 Furamate of 4-( (4-( (4- (2-cyanoethenyl) -2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile |
| 03/09/2006 | WO2006024240A2 Vaccine composition against hepatitis c virus |
| 03/09/2006 | WO2006024120A2 Topical phytotherapeutic compound for the treatment of herpes based on uncaria tomentosa and extraction process for obtaining a vegetal extract from uncaria tomentosa |
| 03/09/2006 | WO2006015035A8 Useful compounds for hpv infection |
| 03/09/2006 | WO2006008470A3 Treatment of tumours |
| 03/09/2006 | WO2006005268A3 Pharmaceutical composition containing polypeptide fragments of serralysins |
| 03/09/2006 | WO2005118644A3 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 03/09/2006 | WO2005014572A8 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 03/09/2006 | US20060053498 Full-length human cdnas encoding potentially secreted proteins |
| 03/09/2006 | US20060052600 Amino-functional chalcones |
| 03/09/2006 | US20060052595 Heterocyclic compounds as ccr5 antagonists |
| 03/09/2006 | US20060052591 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 03/09/2006 | US20060052433 Compound |
| 03/09/2006 | US20060052407 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 03/09/2006 | US20060052403 Novel adenine compound and use thereof |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052389 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 03/09/2006 | US20060052381 Solubilized topoisomerase poisons |
| 03/09/2006 | US20060052371 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding |
| 03/09/2006 | US20060052365 Protease inhibitors |
| 03/09/2006 | US20060052361 Aids therapy; side effect reduction |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052317 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 03/09/2006 | US20060051746 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 03/09/2006 | US20060051411 Antibacterial medicinal composition of enhanced oral absorptivity |
| 03/09/2006 | US20060051378 Mucosal vaccines with chitosan adjuvant and meningococcal antigens |
| 03/09/2006 | US20060051361 Vaccine against Streptococcus pneumoniae |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | US20060051292 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |
| 03/09/2006 | DE102004040630A1 Kombinationstherapie mit Procain Combination therapy with procaine |
| 03/09/2006 | CA2579089A1 Inhibition of viruses using rnase h inhibitors |
| 03/09/2006 | CA2578877A1 Pharmaceutical use of graptopetalum and related plants |
| 03/09/2006 | CA2577924A1 Novel carbapenem compound |
| 03/09/2006 | CA2577918A1 Vaccine composition against hepatitis c virus |
| 03/09/2006 | CA2577812A1 Acylsulfonamide compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 03/09/2006 | CA2577800A1 Topical phytotherapeutic compound for the treatment of herpes based on uncaria tomentosa and extraction process for obtaining a vegetal extract from uncaria tomentosa |
| 03/09/2006 | CA2577273A1 Fumarate of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile |
| 03/09/2006 | CA2576781A1 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 03/09/2006 | CA2572442A1 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 03/09/2006 | CA2570735A1 Treatment of hiv infection by t-cell modulation |
| 03/08/2006 | EP1632488A1 Cyclic tertiary amine compound |
| 03/08/2006 | EP1632479A2 Piperazine derivatives useful as ccr5 antagonists |
| 03/08/2006 | EP1632243A1 Use of hab 18g/cd 147 molecule as target of antiviral antagonist and thus obtained antiviral antagonist |
| 03/08/2006 | EP1632241A1 Preventive and/or remedy for diseases accompanied by tissue destruction |
| 03/08/2006 | EP1632239A1 Pharmaceutical composition comprising a Pseudomonas lindbergii supernatant and a Bacillus coagulans supernatant and its use |
| 03/08/2006 | EP1632232A1 Salt of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile |
| 03/08/2006 | EP1632228A1 Medicinal composition containing triazole compound |
| 03/08/2006 | EP1632224A1 Spill resistant pharmaceutical compositions |
| 03/08/2006 | EP1631670A2 Conserved hbv and hcv sequences useful for gene silencing |
| 03/08/2006 | EP1631575A1 NEW 3-DECLADINOSYL 9a-N -CARBAMOYL AND 9a-N -THIOCARBAMOYL DERIVATIVES OF 9-DEOX-9-DIHYDRO-9a-AZA-9A-HOMOERYTHROMYCIN A |
| 03/08/2006 | EP1631570A1 Naphthyridine derivatives as antibacterial agents |
| 03/08/2006 | EP1631554A2 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection |
| 03/08/2006 | EP1631331A1 A bioabsorbable delivery system |
| 03/08/2006 | EP1631289A2 Anti-hiv benzamide compounds |
| 03/08/2006 | EP1631271A2 Methods and compositions for delivery of catecholic butanes for treatment of tumors |
| 03/08/2006 | EP1631270A2 Methods and compositions for delivery of catecholic butanes for treatment of diseases |
| 03/08/2006 | EP1631255A2 Drug delivery system |
| 03/08/2006 | EP1539734B1 Piperidine quinolyl propyl derivatives and use thereof as antimicrobial agents |
| 03/08/2006 | EP1494703B1 Chemokines mutants having improved oral bioavailability |
| 03/08/2006 | EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 03/08/2006 | EP1438341B1 Antibody stimulating il-1ra production |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | EP1390377B1 New crystal form of azithromycin |
| 03/08/2006 | EP1387841B1 Novel azole or triazole derivatives, method for preparing the same and use thereof as fungicides |
| 03/08/2006 | EP1385821A4 Novel anti-adhesive compounds and uses thereof |
| 03/08/2006 | EP1353926B1 Mikanolide derivatives, their preparation and therapeutic uses |
| 03/08/2006 | EP1349853B1 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections |
| 03/08/2006 | EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 03/08/2006 | EP1347747B1 Method for preparing submicron particle suspensions of pharmaceutical agents |
| 03/08/2006 | EP1343784B1 UREA SUBSTITUTED IMIDAZOQUINOLINE ETHERS and pharmaceutical compositions comprising the same. |
| 03/08/2006 | EP1326589B1 Nanoparticles |
| 03/08/2006 | EP1325009B1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 03/08/2006 | EP1318995B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/08/2006 | EP1290013B1 Apo-ai/aii peptide derivatives |
| 03/08/2006 | EP1276503B1 Screening methods for inhibitors of an acrab and an acrab-like efflux pump |
| 03/08/2006 | EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 03/08/2006 | EP1238086B1 Vaccine for enhancing immune responses to herpes simplex virus |
| 03/08/2006 | EP1198454B1 Mutilin derivatives and their use as antibacterials |
| 03/08/2006 | EP1185659B1 Dna pcv vaccine |
| 03/08/2006 | EP1180041B1 Vaccine against isa virus |
| 03/08/2006 | EP1176959B1 Novel prolines as antimicrobial agents |